News Stories


Featured Stories

View More Featured Stories


Research News from UC Davis Health

  • Hitting cancer with high-intensity ultrasound and immunotherapy: March, 2017 - UC Davis Health System research news
    SACRAMENTO, Calif. (March 23, 2017) - In a new study published today in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint inhibitor and TLR9 agonist) can produce excellent response rates in mouse models of epithelial cancer. They also found that, for the combination to be effective, immunotherapies must come first.
  • UC Davis researchers investigate adult blood-clotting drug for use in severely injured children: March, 2017 - UC Davis Health System research news
    SACRAMENTO, Calif. (March 14, 2017) - UC Davis emergency medicine researchers have been awarded a grant from the National Institutes of Health (National Heart, Lung, and Blood Institute) to investigate the safety and efficacy of a drug known to stop bleeding in injured adults for use in cases of pediatric trauma.
  • Developing new collaborations and technologies: March, 2017 - UC Davis Health System research news
    SACRAMENTO, Calif. (March 7, 2017) - With a $1 million grant from the National Science Foundation (NSF), UC Davis and Boston University will focus on establishing partnerships with industry, academe and government that lead to the development of innovative biophotonic technologies for use in medicine and other scientific disciplines.
  • University of California, Stanford partner on research to improve health in California and nationwide: March, 2017 - UC Davis Health System research news
    SACRAMENTO, Calif. (March 7, 2017) - The University of California Biomedical Research Acceleration, Integration, and Development program (UC BRAID) and Stanford University have formed an alliance to combine resources and develop a coordinated approach to research targeting the health of Californians – a partnership that can serve as a model for collaborations throughout the country.
  • UC Davis joins national consortium to find regenerative treatments for dental and craniofacial tissues: March, 2017 - UC Davis Health System research news
    SACRAMENTO, Calif. (March 7, 2017) - UC Davis will join other California research institutions in a three-year, $12 million effort to find regenerative treatments for dental, oral and craniofacial deformities and injuries.
  • Doctors and patients often disagree on pain treatment goals: March, 2017 - UC Davis Health System research news
    SACRAMENTO, Calif. (March 6, 2017) - Disagreements between doctors and patients over the priorities of pain treatment are common during primary care office visits, new research from UC Davis Health shows. Patients hope to reduce pain intensity and identify the cause, while physicians aim to improve physical function and reduce medication side effects, including dependency.
  • Cerebrospinal fluid shows promise as autism biomarker: March, 2017 - UC Davis Health System research news
    SACRAMENTO, Calif. (March 6, 2017) - Researchers from the UC Davis MIND Institute, University of North Carolina (UNC) and other institutions have found that altered distribution of cerebrospinal fluid (CSF) in high-risk infants can predict whether they will develop autism spectrum disorder (ASD). The study appears today in the journal Biological Psychiatry.
  • UC Davis computational molecular biologist named Sloan fellow to study genetic causes of complex disorders: February, 2017 - UC Davis Health System research news
    SACRAMENTO, Calif. (February 27, 2017) - Fereydoun Hormozdiari, an early-career UC Davis scientist, has been named a 2017 Alfred P. Sloan Research Fellow in Computational & Evolutionary Molecular Biology. He is one of 126 scholars to receive the prestigious award, which comes with $60,000 over two years to conduct leading-edge research.
  • Research linking obesity to immune function and disease gets funding boost: February, 2017 - UC Davis Health System research news
    SACRAMENTO, Calif. (February 23, 2017) - Researchers at UC Davis have received $3.2 million in federal funds to further investigate how obesity and inflammation affect the body’s immune system in fighting cancer.
  • Placenta provides time capsule for autism studies: February, 2017 - UC Davis Health System research news
    SACRAMENTO, Calif. (February 21, 2017) - In two recent studies, researchers at UC Davis have shown that the placenta can provide critical information about early changes to the intra-uterine environment that may influence fetal development and ultimately, children’s brains.

View More Research News From the Health System »

Back to top